These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11698463)

  • 1. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM; Perrin PJ; Farrell JP
    J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection.
    Padigel UM; Farrell JP
    Infect Immun; 2003 Mar; 71(3):1389-95. PubMed ID: 12595456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
    Padigel UM; Kim N; Choi Y; Farrell JP
    J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.
    Compton HL; Farrell JP
    J Immunol; 2002 Feb; 168(3):1302-8. PubMed ID: 11801669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
    Pietrella D; Lupo P; Perito S; Mosci P; Bistoni F; Vecchiarelli A
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):63-70. PubMed ID: 14734188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
    Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of CD28 and CD40 ligand in T cell activation and tolerance.
    Howland KC; Ausubel LJ; London CA; Abbas AK
    J Immunol; 2000 May; 164(9):4465-70. PubMed ID: 10779746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand is required for protective cell-mediated immunity to Leishmania major.
    Campbell KA; Ovendale PJ; Kennedy MK; Fanslow WC; Reed SG; Maliszewski CR
    Immunity; 1996 Mar; 4(3):283-9. PubMed ID: 8624818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.
    Wille U; Villegas EN; Craig L; Peach R; Hunter CA
    Infect Immun; 2002 Dec; 70(12):6940-7. PubMed ID: 12438373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis.
    Okwor I; Uzonna JE
    Cell Immunol; 2016 Nov; 309():32-36. PubMed ID: 27394077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum.
    Zhou P; Seder RA
    J Exp Med; 1998 Apr; 187(8):1315-24. PubMed ID: 9547342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
    Heinzel FP; Rerko RM; Hujer AM
    Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R; Gurunathan S; Nishikomori K; Strober W
    J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM; Scott P
    J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.